Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

US Patent 8138345 · Granted Mar 20, 2012

Estimated economic value: $17,721,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Thiadiazolyl derivatives2025
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors2025
Diacylglyceride O-acyltransferase 2 inhibitors2025
Transmit power control method, terminal, chip system, and system2025
Substituted benzenecarboxamides as IL-17A modulators2025
KHK inhibitors2025
1′-cyano nucleoside analogs and uses thereof2025
3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amin2025
Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl2025
Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl2025
Inhibitors of peptidylarginine deiminases2025
IL-17 ligands and uses thereof2025